IFSO urges prescribing rights for obesity drugs based on competence, not specialty

The International Federation for the Surgery of Obesity and Metabolic Disorders has urged that doctors with suitable training be allowed to prescribe obesity medicines, including GLP-1 receptor agonists, whatever their specialty. The authors say the principle should cover primary care too. They expect prescribers to understand obesity as a long-term condition and to monitor weight, treatment response and muscle function over time. Trained metabolic bariatric surgeons would also be recognised as eligible prescribers.

The statement argues that speciality-based restrictions can shut out experienced doctors, and it counts India among countries that apply them. The reporting does not set out the current Indian rules in detail, so prescribers should check the regulatory position. This is a professional position statement, not a change in law.